Amesite Inc. AMST
and commercializing AI-powered solutions for the healthcare sector, with particular emphasis on the post-acute care market. In fiscal
2025, we completed our pivot from an education-centric model to one firmly anchored in the demands and opportunities of healthcare—a
shift driven by the scale, complexity, and attractive growth potential of this sector.
NurseMagic™ brand: a B2C (direct-to-practitioner) app and a B2B (enterprise) platform. These solutions directly address operational,
Last close
0.62
2026-10-23
Market cap
$3.6M
2026-03-31 share count
52-week range
0.62 - 3.72
Valuation FY2025 figures against the last close
P/S32.7x
P/E—
P/FCF—
EV/EBITDA—
Dividend yield—
Diluted EPS-1.03
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Revenue | $110.5K | $166.9K | $845.0K | $697.0K | $674.6K | $59.7K | — |
| R&D | $691.2K | $1.1M | $1.5M | $3.1M | — | — | — |
| SG&A | $2.5M | $2.9M | $2.5M | $5.2M | $4.6M | $2.0M | — |
| Total operating expenses | $3.7M | $4.7M | $5.1M | $9.8M | $8.6M | $4.1M | — |
| Operating income | -$3.6M | -$4.6M | -$4.2M | -$9.1M | — | — | — |
| Net income | -$3.6M | -$4.4M | -$4.2M | -$9.1M | -$11.6M | -$4.2M | — |
| EPS, basic | -1.03 | -1.73 | -1.68 | -4.67 | -0.59 | -0.27 | — |
| EPS, diluted | -1.03 | -1.73 | -1.68 | -4.67 | -0.59 | — | — |
| Shares, diluted (wtd. avg.) | 3.5M | 2.5M | 2.5M | 1.9M | 19.5M | — | — |
Balance sheet
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | $2.3M | $2.1M | $5.4M | $7.1M | $10.7M | $4.1M | $1.0M |
| Receivables | $6.3K | $30.1K | $15.0K | $14.5K | $51.1K | $61.1K | — |
| Total current assets | $2.4M | $2.5M | $5.5M | $7.7M | $11.1M | — | — |
| Property, plant and equipment | $39.4K | $64.8K | $89.0K | $87.2K | $100.6K | $45.3K | — |
| Other intangibles | — | $644.8K | — | $778.4K | — | — | — |
| Total assets | $3.1M | $3.3M | $6.3M | $8.9M | $12.5M | $5.7M | — |
| Accounts payable | $25.4K | $48.9K | $70.1K | $122.3K | $139.8K | $112.1K | — |
| Total current liabilities | $358.6K | $798.5K | $265.3K | $748.1K | $741.7K | $2.7M | — |
| Retained earnings | -$41.5M | -$37.8M | -$33.4M | -$29.3M | -$20.2M | -$8.6M | — |
| Total equity | $2.7M | $2.5M | $6.1M | $8.1M | $11.7M | $3.0M | $1.8M |
Cash flow
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | -$2.5M | -$2.8M | -$3.2M | -$6.7M | -$5.3M | -$2.8M | — |
| Depreciation and amortisation | $433.8K | $533.7K | $682.5K | $875.6K | $751.5K | $522.3K | — |
| Stock-based compensation | $226.1K | $834.5K | $179.5K | $1.4M | $876.3K | $555.0K | — |
| Capital expenditure | — | $1.2K | $27.1K | $16.6K | $73.4K | $10.8K | — |
| Investing cash flow | -$378.3K | -$375.9K | -$396.0K | -$711.6K | -$842.3K | -$795.7K | — |
| Financing cash flow | $3.1M | — | $1.9M | $3.9M | $12.8M | $6.7M | — |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001213900-25-103104.
Plot the figures US dollars
Income statement
Revenue
Cost of revenue
Gross profit
R&D
SG&A
Total operating expenses
Operating income
Interest expense
Pre-tax income
Income tax
Net income
EPS, basic
EPS, diluted
Shares, diluted (wtd. avg.)
- Revenue
- Gross profit
- Net income
| Fiscal year | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| Revenue | — | $59.7K | $674.6K | $697.0K | $845.0K | $166.9K | $110.5K |
| Gross profit | — | — | — | — | — | — | — |
| Net income | — | -$4.2M | -$11.6M | -$9.1M | -$4.2M | -$4.4M | -$3.6M |
Recent filings and events
- Material agreement signed The company entered an agreement outside the ordinary course of business - a large contract, a credit facility, a merger agreement. Item 1.01
- Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
- Shareholder vote The results of the annual meeting or a special vote. Item 5.07
- Other event The catch-all. The company chose to disclose something that fits no other item, so the content is whatever it says it is. Item 8.01
- Material agreement signed Item 1.01
- Unregistered share sale Shares issued outside a registered offering. Dilution, and for a small company often the way it is funded. Item 3.02
- Other event Item 8.01
- Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
- Regulation FD disclosure Item 7.01
- Delisting notice The exchange has told the company it no longer meets the rules for staying listed - usually price, market cap, or filings that are late. Item 3.01
- Annual report filed A new 10-K. The figures and the business description on this site come from it. Form 10-K
- Auditor changed The company changed auditors. Sometimes routine; historically one of the more reliable warnings that something is wrong. Item 4.01
Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.
Others in SIC 7372
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| MSFT | MICROSOFT CORP | $3.89T | 29.2x | 17.8% |
| PLTR | Palantir Technologies Inc. | $472.16B | 312.3x | 56.2% |
| ORCL | ORACLE CORP | $363.40B | 21.6x | 17.3% |
| CRWD | CrowdStrike Holdings, Inc. | $263.73B | — | 21.7% |
| SHOP | SHOPIFY INC. | $218.48B | 179.4x | 30.1% |
| CRM | Salesforce, Inc. | $204.57B | 31.9x | 9.6% |
| NOW | ServiceNow, Inc. | $164.36B | 95.2x | 20.9% |
| NET | Cloudflare, Inc. | $115.42B | — | 29.8% |